Dec 9, 2021
Psilocybin Cubensis and MDMA therapy has been shown in clinical trials to cure PTSD and depression. Thanks to the work done by the Multidisciplinary Association for Psychedelic Studies (MAPS), psilocybin therapy and MDMA therapy have been approved for clinical trials to discover the healing benefits involved in using these medicines.
After a ground-breaking study at Johns Hopkins University, the world was alerted to the reality that psilocybin cubensis has a powerful ability to heal depression.
MDMA therapy has been shown to relieve and heal symptoms of PTSD. Additionally, plant medicines like Ayahuasca have been shown by MAPS to heal drug addiction, amongst other benefits. Psychedelics are becoming mainstream in our world because their power to overcome trauma is second-to-none.
On this episode of the Beyond Homo Sapien podcast, I spoke with doctoral student Muhsin Corbbrey about the power of psilocybin cubensis and MDMA therapy. At the university of Arizona, Muhsin is comparing the benefits of psilocybin therapy and MDMA therapy against the dangers of mainstream SSRIs and other toxic medicines prescribed by medical professionals.
Listen to this episode to learn how psilocybin therapy and MDMA assisted psychotherapy are healing our world.
The power of psychedelic planets is surfacing. Since the days of our ancestors, the healing ability of these medicines has been known. Here at the end of 2021, the world is waking up and beginning to think for themselves instead of listening to the spoon-fed narrative pushed by the mainstream media. As a result, humanity is healing.